4
Changes in Ownership
aTYR PHARMA INC Filed Acc 0001209191-16-156269
CEO and Director bought 69,000 shares at $2.20 ($151,662)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| MENDLEIN JOHN CEO and Director | 2016-12-19 | Purchase | +69,000 | $2.20 | $151,662 | 324,971 | D: show line 1 in the form |
| Open-market purchases · 69,000 sh · avg $2.20 · $151,662 | |||||||
Loading xslF345X03/doc4.xml…